Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Balkanica LLC
WARNING LETTER
•Balkanica LLC•May 20, 2026

FDA WARNING_LETTER - Balkanica LLC - May 20, 2026

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Balkanica LLC
Record Details

Balkanica LLC, based in Clifton, New Jersey, was issued a formal Warning Letter by the U.S. Food and Drug Administration (FDA) on June 29, 2026. This action followed inspections conducted on July 31, 2023, October 24, 2024, and May 20, 2026, which aimed to evaluate the company’s compliance with the Foreign Supplier Verification Program (FSVP) regulations. These regulations, part of the Federal Food, Drug, and Cosmetic Act, require importers to verify that foreign food suppliers meet U.S. safety standards. The FDA’s investigation revealed that Balkanica LLC failed to develop and implement required verification programs for several imported products, specifically Sunflower Seeds from Iadki Detelina Ltd. and Sheep’s Milk Cheese from Makler Komers LTD, both located in Bulgaria. Although the company indicated it had hired a qualified individual to begin organizing its compliance documents, the FDA deemed this response insufficient because the company failed to provide actual evidence of completed safety evaluations or program implementation. To address these violations, Balkanica LLC is required to submit a written response within 15 working days. This response must include specific documentation, such as completed FSVP records, to prove that corrective actions have been fully implemented. Failure to satisfy these requirements could result in the FDA refusing entry of the company’s imports into the United States or placing the products on a detention list, which allows for seizure without physical examination.

Company
Balkanica LLC
Inspection Date
May 20, 2026
Product Type
Other
People
  • Marvin A. Marenco
  • Theresa Smedley (Director of Investigations Branch)
  • Martin M. Kimani
Open in Dashboard

ID · e0b198a5-8a40-4c9d-8d6b-71a21abbdbc1

Violation Codes8
FD&C Act 80521 U.S.C. 384a21 CFR 2121 CFR 1.502(a)FD&C Act 801(a)(3)21 U.S.C. 381(a)(3)FD&C Act 301(zz)21 U.S.C. 331(zz)

Full citation text and observation details available on the Dashboard.

KeyPedia
Regulatory Data Transformed
Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@globalkeysolutions.net
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.